News

Published on 28 May 2024 on Simply Wall St. via Yahoo Finance

Could The Market Be Wrong About Reckitt Benckiser Group plc (LON:RKT) Given Its Attractive Financial...


Article preview image

It is hard to get excited after looking at Reckitt Benckiser Group's (LON:RKT) recent performance, when its stock has declined 24% over the past three months. However, stock prices are usually driven by a company’s financial performance over the long term, which in this case looks quite promising. Particularly, we will be paying attention to Reckitt Benckiser Group's ROE today.

Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.

LSE.RKT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Rocket Lab USA, Inc. (RKLB) Suffers a Larger Drop Than the General Market: Key...

Rocket Lab USA, Inc. (RKLB) closed the latest trading day at $26.91, indicating a -1.64% change f...

Zacks · via Yahoo Finance 10 Jan 2025

Rocket Lab to Provide Neutron Launch Services for NASA Under VADR Contract

Rocket Lab USA, Inc. (RKLB, Financials) announced that NASA has selected its Neutron rocket to...

GuruFocus.com · via Yahoo Finance 10 Jan 2025

Rocket Lab Expands NASA Partnership With Neutron Under VADR Contract

Rocket Lab USA, Inc. (NASDAQ:RKLB) disclosed an agreement with NASA to include its Neutron rocket...

Benzinga · via AOL 10 Jan 2025

Rocket Companies (NYSE:RKT) Sets New 1-Year Low Following Analyst Downgrade

Rocket Companies, Inc. (NYSE:RKT – Get Free Report) shares reached a new 52-week low on Monday af...

ETF DAILY NEWS 6 Jan 2025

Opinion | The Defining Moments of 2024

Students discuss the noteworthy events of the year.

The Wall Street Journal 31 Dec 2024

Better Growth Stock: Archer Aviation or Rocket Lab USA, Inc.?

Innovative growth stocks can deliver life-changing returns for patient investors who identify...

Motley Fool · via Yahoo Finance 31 Dec 2024

Rocket Pharmaceuticals, Inc. (RCKT): Is This Gene Therapy Stock a Good Buy Right...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article,...

Insider Monkey · via Yahoo Finance 29 Dec 2024

...Charges Tai Mo Shan With Misleading Terra USD Investors, Rocket Companies...

The Consumer Financial Protection Bureau sued Rocket Homes, a division of Rocket Companies, Inc. ...

Benzinga 28 Dec 2024

Consumer Financial Protection Bureau (CFPB) Files Lawsuit to Stop Illegal...

WASHINGTON, D.C. – On Monday, the Consumer Financial Protection Bureau (CFPB) sued Rocket Homes t...

Sierra Sun Times 25 Dec 2024

CFPB Sues Rocket Homes, Jason Mitchell Group Over Alleged Kickback Referral...

Federal regulators filed a lawsuit Monday against Rocket Homes Real Estate and The Jason Mitchell...

RISMedia Real Estate News 24 Dec 2024